Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Home treatment for severe addiction disorders

Official title: A Pilot Study on Home Treatment for Individuals Suffering From Severe Addictive Disorders

Run by University Hospital, Geneva · NCT05563363 · Data updated 2026-11-12

This study tests if treating severe addiction at home can help people stay out of the hospital longer compared to traditional inpatient care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations1 site (Geneva)
StatusRecruiting
StartedDecember 1, 2022
Main results expectedDecember 31, 2025
Study endsMay 31, 2026
Registry record updatedAugust 28, 2025
Trial IDNCT05563363 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and above with a substance use disorder who can communicate in French and consent to randomization.

Probably not a fit

Patients with severe psychiatric conditions, acute suicidal ideation, or significant medical comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the effectiveness of home treatment (HT) for individuals suffering from severe substance use disorders compared to traditional inpatient treatment. The study will focus on readmission rates within six months post-discharge, as previous data indicates a high rate of readmissions during this period. Participants will be randomly assigned to either home treatment or standard inpatient care, with the goal of preparing for a larger-scale study if the pilot proves successful.

Why it matters

Potential benefit: If successful, this approach could provide a more accessible and effective treatment option for patients with severe addictive disorders.

How similar studies have gone: Previous implementations of home treatment in adult psychiatry have shown success, suggesting potential for this approach in addiction treatment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Substance use disorder
* age 18 or above
* sufficient french language skills
* competent subjects
* consent to randomization progress

Exclusion Criteria:

* organic brain disease or developmental disorder
* non voluntary admission
* severe somatic comorbidity
* History of complicated substance withdrawal
* acute suicidal ideation
* aggressive behavior
* acute psychiatric disease such as mania or psychosis
* distance to center (must be reachable within 60 minutes)

Where it's running

  • Geneva University Hospital
    Geneva, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.